ACE2 and COVID-19: When studying the African American population, researchers noted that they have a decreased ACE2 expression but still experienced higher than normal rates of COVID-19 infection; this is contraindicatory to the expected decreased risk of COVID-19 in this group due to lower ACE2 expression.